Psychedelic Therapeutics & Drug Development 2024

The 4th Annual Psychedelic Therapeutics & Drug Development Conference, May 23-24, 2024, in Boston, MA, builds on the success of its previous editions by bringing together the world’s leading researchers, academics, industry professionals, non-profit organizations, and government representatives. This event has been organized to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet needs.

Participants can look forward to insightful discussions highlighting the progress being made towards regulatory approval of a variety of psychedelic substances with the potential to treat conditions such as inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Featuring a lineup of expert speakers and panelists, the conference will cover crucial topics, including Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data, among others. The event has been meticulously curated to provide practical guidance, foster discussion, and facilitate networking opportunities for key stakeholders in this rapidly growing field.

By uniting the brightest minds and fostering interdisciplinary dialogue, the 4th Annual Psychedelic Therapeutics & Drug Development Conference aims to accelerate advancements in psychedelic research, therapy, and policy, ultimately contributing to the responsible development and integration of these transformative medicines.

Details regarding the speakers for the 2024 conference will be announced soon.